UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiviral Agents in Development for Zika Virus Infections

Pharmaceuticals (Basel, Switzerland), 2019-06, Vol.12 (3), p.101

2019

Volltextzugriff (PDF)

Preclinical and clinical developments for combination treatment of influenza

PLoS pathogens, 2022-05, Vol.18 (5), p.e1010481-e1010481

2022

Volltextzugriff (PDF)

Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains

The Journal of infectious diseases, 2020-01, Vol.221 (1), p.63-70

2020

Volltextzugriff (PDF)

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice

Emerging infectious diseases, 2022-11, Vol.28 (11), p.2352-2355

2022

Volltextzugriff (PDF)

Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses

Viruses, 2023-12, Vol.15 (12), p.2447

2023

Volltextzugriff (PDF)

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

The New England journal of medicine, 2009-12, Vol.361 (23), p.2296-2297

2009

Volltextzugriff (PDF)

Characterization of Multidrug-Resistant Influenza A/H3N2 Viruses Shed during 1 Year by an Immunocompromised Child

Clinical infectious diseases, 2006-12, Vol.43 (12), p.1555-1561

2006

Volltextzugriff (PDF)

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses

Viruses, 2020-10, Vol.12 (10), p.1139

2020

Volltextzugriff (PDF)

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice

Frontiers in immunology, 2023-05, Vol.14, p.1163858

2023

Volltextzugriff (PDF)

Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge

mBio, 2015-10, Vol.6 (5), p.e01487-e01415

2015

Volltextzugriff (PDF)

Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic

Scientific reports, 2022-07, Vol.12 (1), p.12962-12962, Article 12962

2022

Volltextzugriff (PDF)

Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses

The Journal of infectious diseases, 2010-03, Vol.201 (5), p.740-745

2010

Volltextzugriff (PDF)

Zika Virus Isolation, Purification, and Titration

Methods in molecular biology (Clifton, N.J.), 2020, Vol.2142, p.9

Baz, Mariana

2020

Volltextzugriff (PDF)

Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds

Antiviral therapy, 2006-01, Vol.11 (8), p.971-976

2006

Volltextzugriff (PDF)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus

Viruses, 2018-11, Vol.10 (11), p.610

2018

Volltextzugriff (PDF)

Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice

Vaccines (Basel), 2024-08, Vol.12 (8), p.902

2024

Volltextzugriff (PDF)

Epigallocatechin Gallate and Isoquercetin Synergize With Remdesivir to Reduce SARS-CoV-2 Replication In Vitro

Frontiers in virology (online), 2022-07, Vol.2

2022

Volltextzugriff (PDF)

ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines

Vaccines (Basel), 2021-11, Vol.9 (11), p.1350

2021

Volltextzugriff (PDF)

Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory-Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections

Clinical infectious diseases, 2010-11, Vol.51 (9), p.1033-1041

2010

Volltextzugriff (PDF)

Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

Frontiers in immunology, 2022-10, Vol.13, p.930252

2022

Volltextzugriff (PDF)

Replication and Immunogenicity of Swine, Equine, and Avian H3 Subtype Influenza Viruses in Mice and Ferrets

Journal of Virology, 2013-06, Vol.87 (12), p.6901-6910

2013

Volltextzugriff (PDF)

Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets

PLoS pathogens, 2010-07, Vol.6 (7), p.e1001015-e1001015

2010

Volltextzugriff (PDF)

A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus

The Journal of infectious diseases, 2009-01, Vol.199 (2), p.180-183

2009

Volltextzugriff (PDF)

Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada

Heliyon, 2024-05, Vol.10 (10), p.e31026-e31026, Article e31026

2024

Volltextzugriff (PDF)

Antiviral effect of honey extract Camelyn against SARS-CoV-2

Journal of advanced biotechnology and experimental therapeutics, 2021, Vol.4 (3), p.290-297

2021

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(78)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antiviral Agents in Development for Zika Virus Infections

Preclinical and clinical developments for combination treatment of influenza

Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice

Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

Characterization of Multidrug-Resistant Influenza A/H3N2 Viruses Shed during 1 Year by an Immunocompromised Child

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice

Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge

Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic

Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses

Zika Virus Isolation, Purification, and Titration

Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus

Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice

Epigallocatechin Gallate and Isoquercetin Synergize With Remdesivir to Reduce SARS-CoV-2 Replication In Vitro

ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines

Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory-Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections

Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

Replication and Immunogenicity of Swine, Equine, and Avian H3 Subtype Influenza Viruses in Mice and Ferrets

Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets

A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus

Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada

Antiviral effect of honey extract Camelyn against SARS-CoV-2

Suchergebnisse filtern